Study for AZD4360 in Participants With Advanced Solid Tumours

Clinical trial NCT06921928 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06921928
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Gastroesophageal Junction Cancer Biliary Tract Cancer Pancreatic Ductal Adenocarcinoma

Start date: 2025-04-29
Primary completion: 2027-03-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.